Hepatitis B e antigen and the risk of hepatocellular carcinoma

New England Journal of Medicine

Volumn 347, Issue 3, 2002, Pages 168-174

  Yang, Hwai I ^a   Lu, Sheng Nan ^b   Liaw, Yun Fan ^c   You, San Lin ^a   Sun, Chien An ^d   Wang, Li Yu ^e   Hsiao, Chuhsing K ^a   Chen, Pei Jer ^f   Chen, Ding Shinn ^f   Chen, Chien Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^e TZU CHI UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CIGARETTE SMOKING; CONFIDENCE INTERVAL; DEATH CERTIFICATE; DISEASE ASSOCIATION; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER CELL; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; RISK ASSESSMENT; RISK FACTOR; SERUM; TAIWAN; VIRUS REPLICATION;

EID: 84984555343     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa013215     Document Type: Article

References (31)

1. Natural history of chronic hepatitis B virus infection: An immunopathological study
2. From hepatitis to hepatoma: Lessons from type B viral hepatitis
3. Epidemiological characteristics and risk factors of hepatocellular carcinoma
4. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22 707 men in Taiwan
5. Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection
6. Hepatitis B e antigen seroconversion: Effects of lamivudine alone or in combination with interferon alpha
7. Sex difference in chronic hepatitis B virus infection: An appraisal based on the status of hepatitis B e antigen and antibody
8. Age-specific prevalence and significance of hepatitis B e antigen and antibody in chronic hepatitis B virus infection in Taiwan: A comparison among asymptomatic carriers, chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma
9. A case-control study of primary hepatocellular carcinoma in Taiwan
10. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma
11. Hepatitis B virus e antigen and primary hepatocellular carcinoma
12. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan
13. Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma
14. Nonparametric inference for a family of counting processes
15. A large sample study of the life table and product limit estimates under random censorship
16. Small sample and efficiency results for the Nelson-Aalen estimator
17. Serological markers of hepatitis B virus and alpha-fetoprotein levels preceding primary hepatocellular carcinoma in Alaskan Eskimos
18. Hepatitis viruses and hepatocellular carcinoma
19. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
20. DNA topoisomerases
21. Biology of disease: Free radicals and tissue injury
22. Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinoma
23. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis
24. Hepatocarcinogenicity of the woodchuck hepatitis virus
25. HBx gene of hepatitis B virus induces liver cancer in transgenic mice
26. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma
27. Hepatitis B virus transcriptional activators: Mechanisms and possible role in oncogenesis
28. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma
29. Abrogation of p53-induced apoptosis by the hepatitis B virus X gene
30. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B